Overview: Total Cholesterol/HDL Ratio TestIntroduction: The Total Cholesterol/HDL Ratio Test calculates total cholesterol/HDL ratio to assess heart disease risk, helping guide lifestyle or medical interventions for cardiovascular health. Affecting 1 in 3 adults, high ratios pose diagnostic challenges due to silent progression. Following 2023 American Heart Association (AHA) guidelines, it uses enzymatic assay for high accuracy, supporting biochemistry screening. This test is essential for diagnosis, treatment planning, and improving outcomes in cardiology.
Other Names: Chol/HDL Ratio Test, Cardiac Risk Assay.
FDA Status: FDA-approved test, meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Cholesterol/HDL ratio testing began in the 1970s with research by Kannel, who linked it to heart disease. Enzymatic assay advancements by Roche improved detection, surpassing earlier manual methods.
Purpose: Calculates total cholesterol/HDL ratio to assess heart disease risk, guides statin therapy or lifestyle changes, and evaluates patients with risk factors, aiming to prevent events.
Test Parameters: Total cholesterol/HDL ratio
Pretest Condition: Fasting required. Collect serum or plasma. Report history of cardiovascular issues.
Specimen: Serum (SST, 2-5 mL), Plasma (NaHep, 2-4 mL); 2 mL serum in SST. Transport in a biohazard container.
Sample Stability at Room Temperature: 6 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document heart disease risk factors. Include current medications or family history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., heart attack), and sample collection risks.
Procedural Considerations: Uses enzymatic assay to calculate ratio, requiring labs with analyzers. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample hemolysis or contamination can affect results. Medications may alter levels, requiring correlation.
Clinical Significance: High ratio suggests heart disease risk, guiding interventions. Early management might prevent events, while untreated cases lead to complications. Normal ratio may require monitoring.
Specialist Consultation: Consult a cardiologist for interpretation.
Additional Supporting Tests: Lipid panel, ECG, or stress test to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with clinical status needed. False results possible with improper fasting.
References: AHA Guidelines, 2023; Circulation, Kannel WB, 2022.
